Glenview Capital
Larry Robbins · CIK 0001138995 · latest 13F for 2026-06-30 filed 2026-08-14
Estimated from 13F holdings — long US equities only; follow-the-filing returns are net of an assumed 10 bps per unit of turnover.
About the fund
Glenview Capital Management is a New York-based, privately held investment management firm founded in 2000 by Larry Robbins. The firm manages capital for qualified investors through a series of private investment funds, employing fundamental research and individual security selection across long/short equity and opportunistic strategies.
Strategy
Long/short equity, opportunistic, and healthcare-focused strategies using a GARP (Growth at a Reasonable Price) approach.
Investment approach
Glenview employs a bottom-up, fundamental research process focused on individual security selection. The firm utilizes a Growth at a Reasonable Price (GARP) style, often combined with contrarian, hidden value, or arbitrage strategies. Its investment team is structured by industry groups, and the firm frequently engages in Suggestivism, where it shares perspectives on long-term value creation with portfolio company management and boards.
History
Glenview Capital Management was founded in 2000 by Larry Robbins after he left Omega Advisors. The firm is a New York-based investment management firm that manages capital for qualified investors through various private investment funds. Over its history, the firm has engaged in activist-style communications with portfolio companies, a practice it refers to as Suggestivism.
Notable positions & campaigns
- Health Management Associates (HMA)2013 — Glenview objected to the merger terms and successfully pushed to replace the Board of Directors.
- Tenet Healthcare2016 — Glenview became the largest shareholder in the hospital chain.
- Dow Chemical / DowDuPont2017 — Glenview pushed for changes to the breakup plan of the combined company.
- Cigna / Express Scripts2018 — Glenview publicly supported the acquisition of Express Scripts by Cigna.
Profile generated 2026-10-09 from public sources; may be incomplete or out of date.
- Founded by
- Larry Robbins
- Founded
- 2000
- HQ
- New York, US
- Reported AUM
- $6.4bn (as of 2026-03-31)
Management
- Larry RobbinsChief Investment Officer
- John RodinChief Executive Officer
- Jon AnselPortfolio Manager
- Tim SolimanPortfolio Manager
- Mark Joseph HorowitzPresident and General Counsel
Holdings heatmap
Latest 13F (2026-06-30): top 42 positions grouped by sector, sized by weight, coloured by the change in weight since the previous 13F.
Holdings map
Each tile is a position, sized by reported value and coloured by the stock's own price return (red down, green up) — the LiquidRound / finviz-style map.
Copy portfolio vs SPY
Growth of $1 following each filing the trading day after it was filed.
Top holdings
Latest 13F (2026-06-30).
| # | Ticker | Value | Weight |
|---|---|---|---|
| 1 | GPN | $646M | 12.9% |
| 2 | CVS | $499M | 10.0% |
| 3 | THC | $418M | 8.4% |
| 4 | TMO | $314M | 6.3% |
| 5 | AMZN | $303M | 6.1% |
| 6 | A | $262M | 5.2% |
| 7 | DHR | $218M | 4.4% |
| 8 | META | $201M | 4.0% |
| 9 | AMD | $173M | 3.5% |
| 10 | — | $172M | 3.4% |
| 11 | VTRS | $157M | 3.1% |
| 12 | UBER | $129M | 2.6% |
| 13 | CNC | $121M | 2.4% |
| 14 | BFLY | $121M | 2.4% |
| 15 | CI | $114M | 2.3% |
| 16 | HUM | $101M | 2.0% |
| 17 | XYZ | $91M | 1.8% |
| 18 | DKS | $91M | 1.8% |
| 19 | — | $82M | 1.6% |
| 20 | ONTO | $78M | 1.6% |
| 21 | LLY | $69M | 1.4% |
| 22 | UAL | $67M | 1.3% |
| 23 | EYE | $59M | 1.2% |
| 24 | CSCO | $49M | 1.0% |
| 25 | ESI | $47M | 0.9% |
Sector mix
Top-25 holdings by weight.
Changes this quarter
| Move | Ticker | Prev wt | Now wt |
|---|---|---|---|
| trimmed | CVS | 15.9% | 10.0% |
| new | A | 0.0% | 5.2% |
| added | DHR | 0.8% | 4.4% |
| exited | DXC | 3.0% | 0.0% |
| added | TMO | 3.3% | 6.3% |
| exited | GTM | 2.6% | 0.0% |
| added | META | 1.9% | 4.0% |
| trimmed | — | 5.4% | 3.4% |
| new | LLY | 0.0% | 1.4% |
| trimmed | CI | 3.6% | 2.3% |
| added | GPN | 11.6% | 12.9% |
| exited | USFD | 1.0% | 0.0% |
| exited | Z | 0.9% | 0.0% |
| trimmed | AMAT | 1.8% | 0.9% |
| new | MKSI | 0.0% | 0.9% |
| exited | LAD | 0.9% | 0.0% |
| new | STM | 0.0% | 0.8% |
| new | ABBV | 0.0% | 0.7% |
| exited | LION | 0.7% | 0.0% |
| new | — | 0.0% | 0.7% |
Quarterly copy returns
Each 13F held from the day after filing until the next filing.
| 13F period | Copy | SPY | Alpha | Coverage |
|---|---|---|---|---|
| 2026-06-30 | -1.0% | +0.4% | -1.4% | 78% |
| 2026-03-31 | +10.3% | +4.9% | +5.4% | 80% |
| 2025-12-31 | +10.2% | +7.9% | +2.3% | 74% |
| 2025-09-30 | +3.8% | +3.4% | +0.4% | 70% |
| 2025-06-30 | +2.0% | +3.7% | -1.7% | 70% |
| 2025-03-31 | +7.7% | +8.6% | -0.9% | 71% |
| 2024-12-31 | -8.3% | -2.5% | -5.7% | 70% |
| 2024-09-30 | +7.1% | +4.7% | +2.3% | 73% |
| 2024-06-30 | +1.5% | +6.2% | -4.7% | 70% |
| 2024-03-31 | +0.8% | +4.9% | -4.1% | 67% |
| 2023-12-31 | -3.3% | +5.6% | -9.0% | 69% |
| 2023-09-30 | +17.1% | +12.1% | +5.0% | 67% |
| 2023-06-30 | -1.4% | +1.9% | -3.3% | 63% |
| 2023-03-31 | +7.0% | +8.4% | -1.3% | 70% |
| 2022-12-31 | -4.1% | -0.5% | -3.5% | 70% |
| 2022-09-30 | +3.7% | +4.4% | -0.7% | 72% |
Filing dates
- 2026-08-1413F-HR for 2026-06-30 · $5.5B · 45 rows
- 2026-05-1513F-HR for 2026-03-31 · $4.0B · 44 rows
- 2026-02-1713F-HR for 2025-12-31 · $4.9B · 57 rows
- 2025-11-1413F-HR for 2025-09-30 · $4.5B · 54 rows
- 2025-08-1413F-HR for 2025-06-30 · $3.6B · 43 rows
- 2025-05-1513F-HR for 2025-03-31 · $4.1B · 45 rows
- 2025-02-1413F-HR for 2024-12-31 · $4.0B · 36 rows
- 2024-11-1413F-HR for 2024-09-30 · $5.2B · 46 rows
- 2024-08-1413F-HR for 2024-06-30 · $5.1B · 48 rows
- 2024-05-1513F-HR for 2024-03-31 · $5.7B · 45 rows
- 2024-02-1413F-HR for 2023-12-31 · $4.7B · 44 rows
- 2023-11-1413F-HR for 2023-09-30 · $4.4B · 52 rows
Use it with your AI
A public skill.md describes this copy portfolio (rules + parameters) for ChatGPT or Claude.
Copy this fund
Start a paper copy-bot that rebalances the day after each new filing.
Start a copy-bot